PRESBYTERIAN ST. LUKES MEDICAL CENT
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $1.4M
- Transactions
- 363
- Companies
- 40
- Average per transaction
- $3,738
Who reported the payments
| Celularity Inc. | $239,328 |
| Angiodynamics, Inc. | $183,483 |
| Jazz Pharmaceuticals Inc. | $170,450 |
| National Marrow Donor Program | $164,675 |
| Seagen Inc. | $67,910 |
| Stryker | $49,642 |
| Merck | $49,050 |
| Bristol Myers Squibb | $45,119 |
| KARL Storz Endoscopy-america | $40,183 |
| Barco, Inc. | $32,250 |
| Abbott | $28,565 |
| Aesculap Implant Systems, LLC | $23,782 |
| Medtronic | $20,000 |
| Boston Scientific | $19,686 |
| Rigel Pharmaceuticals, Inc. | $14,000 |
| Livanova USA, Inc. | $11,520 |
| Johnson & Johnson | $11,033 |
| E.r. Squibb & Sons, L.L.C. | $11,000 |
| Amgen | $10,500 |
| Incyte Corporation | $9,473 |
| Astellas Pharma US Inc | $9,000 |
| Astrazeneca UK Limited | $9,000 |
| Medical Device Business Services, Inc. | $8,750 |
| Conmed Corporation | $8,500 |
| Olympus America Inc. | $8,454 |
| Sanofi | $8,000 |
| Linvatec Corporation | $7,581 |
| Gilead | $6,000 |
| AstraZeneca | $6,000 |
| ADC Therapeutics America, Inc. | $6,000 |
| Genmab U.S., Inc. | $6,000 |
| Pharmacyclics LLC, An Abbvie Company | $5,548 |
| Ortho-clinical Diagnostics, Inc. | $5,519 |
| GE HealthCare | $5,387 |
| Masimo Corporation | $5,208 |
| Microvention, Inc. | $5,100 |
| Balt USA, LLC | $4,500 |
| Takeda Pharmaceuticals U.S.A., Inc. | $3,000 |
| Teva Pharmaceuticals USA, Inc. | $3,000 |
| Sobi, Inc | $3,000 |